C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1/2 and Akt in gastric cancer

[1]  Zheng Wang,et al.  CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. , 2015, Cancer letters.

[2]  Wen-Chang Chang,et al.  Nucleolin enhances internal ribosomal entry site (IRES)-mediated translation of Sp1 in tumorigenesis. , 2014, Biochimica et biophysica acta.

[3]  G. Dionigi,et al.  Laparoscopic gastrectomy for gastric cancer : Current evidences , 2014 .

[4]  R. Seruca,et al.  Causes and consequences of microsatellite instability in gastric carcinogenesis. , 2014, World journal of gastroenterology.

[5]  P. Elumalai,et al.  Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. , 2014, The Journal of nutritional biochemistry.

[6]  Y. Assaraf,et al.  The folate receptor as a rational therapeutic target for personalized cancer treatment. , 2014, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[7]  W. Zeng,et al.  CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production. , 2014, Experimental and molecular pathology.

[8]  I. Chowdhury,et al.  Prohibitins Role in Cellular Survival Through Ras‐Raf‐MEK‐ERK Pathway , 2014, Journal of cellular physiology.

[9]  N. Shen,et al.  A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis , 2014, Oncotarget.

[10]  Peng Zhang,et al.  Phosphorylation and changes in the distribution of nucleolin promote tumor metastasis via the PI3K/Akt pathway in colorectal carcinoma , 2014, FEBS letters.

[11]  H. Liang,et al.  Clinical significance of lymph node metastasis in gastric cancer. , 2014, World journal of gastroenterology.

[12]  Bo Zhang,et al.  The Effects of the CCR6/CCL20 Biological Axis on the Invasion and Metastasis of Hepatocellular Carcinoma , 2014, International journal of molecular sciences.

[13]  E. Raymond,et al.  MEK in cancer and cancer therapy. , 2014, Pharmacology & therapeutics.

[14]  G. Wang,et al.  SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial–mesenchymal transition via ERK and PI3K/AKT pathway , 2014, Medical Oncology.

[15]  S. O'Dea,et al.  Regulation of epithelial to mesenchymal transition by bone morphogenetic proteins. , 2013, Cellular signalling.

[16]  L. Ding,et al.  Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma , 2013, Diagnostic Pathology.

[17]  A. Giordano,et al.  Glycosilated nucleolin as marker for human gliomas , 2012, Journal of cellular biochemistry.

[18]  Chin-Tarng Lin,et al.  Nucleolin antisense oligodeoxynucleotides induce apoptosis and may be used as a potential drug for nasopharyngeal carcinoma therapy. , 2011, Oncology reports.

[19]  J. Shih,et al.  The EMT regulator slug and lung carcinogenesis. , 2011, Carcinogenesis.

[20]  Jianda Hu,et al.  DIGE-based proteomic analysis identifies nucleophosmin/B23 and nucleolin C23 as over-expressed proteins in relapsed/refractory acute leukemia. , 2011, Leukemia research.

[21]  Wei Li,et al.  Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension. , 2010, Proceedings of the American Thoracic Society.

[22]  Daekyu Sun,et al.  Identification and Characterization of Nucleolin as a c-myc G-quadruplex-binding Protein* , 2009, The Journal of Biological Chemistry.

[23]  N. Morrell,et al.  TGF-beta and BMPR-II pharmacology--implications for pulmonary vascular diseases. , 2009, Current opinion in pharmacology.

[24]  A. Hovanessian.  Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin , 2006, Cell Research.

[25]  Di Chen,et al.  The BMP signaling and in vivo bone formation. , 2005, Gene.

[26]  R. Derynck,et al.  Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.

[27]  R. Derynck,et al.  Smads: transcriptional activators of TGF-beta responses. , 1998, Cell.